Dasatinib Teva 20 mg filmom obložene tablete
| Name | Dasatinib Teva 20 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-129638106 |
| Active Substance | dasatinib hidrat |
| Composition | jedna filmom obložena tableta sadrži 20 mg dasatiniba (u obliku hidrata) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 27.04.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/25 |
| Registration Number | 381-12-01/70-23-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EA02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
